UCB SA (UCB.BR)

EUR 187.45

(0.83%)

EBITDA Summary of UCB SA

  • UCB SA's latest annual EBITDA in 2023 was 1.26 Billion EUR , down -1.52% from previous year.
  • UCB SA's latest quarterly EBITDA in 2024 Q2 was 644 Million EUR , down 0.0% from previous quarter.
  • UCB SA reported an annual EBITDA of 1.16 Billion EUR in 2022, down -32.99% from previous year.
  • UCB SA reported an annual EBITDA of 1.59 Billion EUR in 2021, up 10.44% from previous year.
  • UCB SA reported a quarterly EBITDA of 794 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • UCB SA reported a quarterly EBITDA of N/A for 2023 FY, down -1.52% from previous quarter.

Annual EBITDA Chart of UCB SA (2023 - 2002)

Historical Annual EBITDA of UCB SA (2023 - 2002)

Year EBITDA EBITDA Growth
2023 1.26 Billion EUR -1.52%
2022 1.16 Billion EUR -32.99%
2021 1.59 Billion EUR 10.44%
2020 1.3 Billion EUR -4.72%
2019 1.33 Billion EUR -0.21%
2018 1.4 Billion EUR 10.15%
2017 1.27 Billion EUR 23.64%
2016 1.08 Billion EUR 24.0%
2015 829 Million EUR 38.17%
2014 600 Million EUR 10.29%
2013 544 Million EUR -12.54%
2012 637 Million EUR -16.62%
2011 610 Million EUR 2.05%
2010 430 Million EUR -44.41%
2009 1 Billion EUR 74.63%
2008 270 Million EUR 6.96%
2007 545 Million EUR 0.28%
2006 678 Million EUR 18.98%
2005 503 Million EUR -28.88%
2004 355 Million EUR 4.01%
2003 797.61 Million EUR -15.45%
2002 829.74 Million EUR 0.0%

Peer EBITDA Comparison of UCB SA

Name EBITDA EBITDA Difference
ABIONYX Pharma SA -3.29 Million EUR 38671.429%
ABIVAX Société Anonyme -133.2 Million EUR 1052.653%
Adocia SA -22.73 Million EUR 5682.439%
Aelis Farma SA -6.34 Million EUR 20093.698%
Biophytis S.A. -13.8 Million EUR 9292.988%
Advicenne S.A. -6.24 Million EUR 20423.511%
genOway Société anonyme 6.35 Million EUR -19881.892%
IntegraGen SA -52.5 Thousand EUR 2417104.743%
Medesis Pharma S.A. -3.84 Million EUR 33104.897%
Neovacs S.A. -8.44 Million EUR 15118.558%
NFL Biosciences SA -4.04 Million EUR 31438.734%
Plant Advanced Technologies SA 72.53 Thousand EUR -1749520.847%
Quantum Genomics Société Anonyme -2.87 Million EUR 44262.479%
Sensorion SA -22.31 Million EUR 5787.062%
Theranexus Société Anonyme -7.38 Million EUR 17278.29%
TME Pharma N.V. -5.07 Million EUR 25119.716%
Valbiotis SA -6.95 Million EUR 18345.866%
TheraVet SA -517.33 Thousand EUR 245395.127%
Valerio Therapeutics Société anonyme -18.91 Million EUR 6808.606%
argenx SE -199.5 Million EUR 736.071%
BioSenic S.A. -6.79 Million EUR 18772.749%
Celyad Oncology SA -7.76 Million EUR 16446.773%
DBV Technologies S.A. -79.53 Million EUR 1695.608%
Galapagos NV 51.03 Million EUR -2386.431%
Genfit S.A. -28.05 Million EUR 4623.903%
GeNeuro SA -14.31 Million EUR 8963.155%
Hyloris Pharmaceuticals SA -14.98 Million EUR 8571.295%
Innate Pharma S.A. -7.57 Million EUR 16845.843%
Inventiva S.A. -101.84 Million EUR 1345.974%
MaaT Pharma SA -19.74 Million EUR 6528.571%
MedinCell S.A. -20.04 Million EUR 6430.44%
Nanobiotix S.A. -34.01 Million EUR 3830.268%
Onward Medical N.V. -35.23 Million EUR 3701.635%
Oryzon Genomics S.A. -4.43 Million EUR 28723.901%
OSE Immunotherapeutics SA -23.26 Million EUR 5554.311%
Oxurion NV -16.72 Million EUR 7685.63%
Pharming Group N.V. 4.98 Million EUR -25376.991%
Poxel S.A. -12.17 Million EUR 10519.575%
GenSight Biologics S.A. -21.73 Million EUR 5939.853%
Transgene SA -27.02 Million EUR 4795.826%
Financière de Tubize SA 184.57 Thousand EUR -687440.296%
Valneva SE -64.51 Million EUR 2066.923%
Vivoryon Therapeutics N.V. -28.35 Million EUR 4575.717%